InFLAMES Lippulaiva
Henkilöt
1/3
Julkaisut
39/362
- Benchmarking methods for detecting differential states between conditions from multi-subject single-cell RNA-seq data (2022)
- Benefits of Mandated Registries for Generating Real-World Outcome Data (2023)
- Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments (2024)
- Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors : The phase I/II first-in-human MATINS trial (2023)
- Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial (2025)
Turun yliopiston Tutkimustietojärjestelmän portaali